Syneron Candela Announces Launch of Direct Operation in Korea

Oct 01, 2018

Syneron Candela Korea Co. Ltd focused on enhancing Customer Service in Growth Markets

WAYLAND, MASSACHUSETTS, October 1, 2018 - Syneron Candela announces the opening of Syneron Candela Korea Co Ltd, a new headquarters designed to support all commercial activities for the entire Syneron Candela portfolio of products in Korea.

Formally known as Syneron Candela (Korea) Medical Technologies Co Ltd, the new entity will provide Syneron Candela customers with direct support to address capital needs for their practice as well as a high level of service, technical, education, training and clinical support, according to a media release from Syneron Candela.

“Our decision to go direct in Korea reflects our vision to be the leading aesthetic medical device company and to providing the highest level of customer support worldwide,” says Geoffrey Crouse, chief executive officer of Syneron Candela, in the release.

“The Korean market is the second largest aesthetic market in Asia,” Crouse suggests. “Our significant presence in Korea, coupled with our service, sales and clinical infrastructure, well positions us to provide our customers the highest levels of support well beyond their purchase of a Syneron Candela product.”

“We envision strong growth for Syneron Candela Korea Co Ltd,” states Robert Ruck, president of Syneron Candela Asia Pacific. “We look forward to playing a key role in the success of our customers’ practices and to provide them with all the benefits of a direct operation in their local market. We wish to thank our past distribution partner, ShinHan, for their outstanding partnership and support to our customers over the years,” he added.

“As a physician who has worked with Syneron Candela’s products for many years, I am pleased to see the opening of the company’s new Korean headquarters,” adds Dr Geun Soo Lee, the vice president for the Association of Korean Dermatologists, the release continues. “It is a strong sign of Syneron Candela’s commitment to the many medical practices in Korea which have entrusted them with providing equipment to ensure the very best care for our patients.”

Candela

Candela is a leading global aesthetic device company with an extensive product portfolio and an expansive global direct commercial infrastructure. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including hair removal, wrinkle reduction, tattoo removal, women's health treatments, facial resurfacing, traumatic and surgical scar treatments, body contouring, improving the skin's appearance through the treatment of benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. In addition to Vbeam, Candela has a wide portfolio of trusted, leading products including the Gentle family of products, PicoWay, Profound, CO2RE, CO2RE Intima, elōs Plus, UltraShape and VelaShape. Acquired by Apax Partners in 2017, the Company markets, services and supports its products in 86 countries. It has offices in the United States, Australia, Canada, China, France, Germany, Hong Kong, Israel, Italy, Japan, Portugal, Spain and the United Kingdom and utilizes a network of distributors for other international markets.

CONTACT
PATIENTS